Mona Landin‐Olsson

10.3k total citations · 1 hit paper
197 papers, 7.5k citations indexed

About

Mona Landin‐Olsson is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Mona Landin‐Olsson has authored 197 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Genetics, 108 papers in Endocrinology, Diabetes and Metabolism and 98 papers in Surgery. Recurrent topics in Mona Landin‐Olsson's work include Diabetes and associated disorders (114 papers), Pancreatic function and diabetes (87 papers) and Diabetes Management and Research (77 papers). Mona Landin‐Olsson is often cited by papers focused on Diabetes and associated disorders (114 papers), Pancreatic function and diabetes (87 papers) and Diabetes Management and Research (77 papers). Mona Landin‐Olsson collaborates with scholars based in Sweden, United States and Denmark. Mona Landin‐Olsson's co-authors include Åke Lernmark, G. Sundkvist, Gisela Dahlquist, Ingrid Kockum, Per‐Anders Jansson, Bo Åhrén, David Holmes, Carina Törn, Maria Svensson and Håkan Olsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Mona Landin‐Olsson

193 papers receiving 7.2k citations

Hit Papers

Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Su... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes
    2004 607 citations Mona Landin‐Olsson et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona Landin‐Olsson Sweden 48 4.6k 3.9k 3.7k 784 720 197 7.5k
Edwin Gale United Kingdom 35 4.3k 0.9× 3.0k 0.8× 2.7k 0.7× 1.1k 1.4× 413 0.6× 74 6.6k
Peter G. Colman Australia 50 6.7k 1.5× 4.2k 1.1× 5.1k 1.4× 1.4k 1.8× 1.0k 1.4× 229 11.3k
Ruth Frikke‐Schmidt Denmark 45 2.6k 0.6× 994 0.3× 3.6k 1.0× 1.6k 2.0× 460 0.6× 202 7.6k
Christophe De Block Belgium 37 3.4k 0.7× 1.7k 0.4× 2.4k 0.6× 730 0.9× 359 0.5× 187 7.1k
Yasuhiko Iwamoto Japan 50 4.9k 1.1× 1.7k 0.4× 2.2k 0.6× 2.8k 3.5× 295 0.4× 272 10.5k
Ian F. Godsland United Kingdom 52 4.3k 0.9× 1.9k 0.5× 1.5k 0.4× 1.4k 1.8× 225 0.3× 176 9.3k
Stephen C. Bain United Kingdom 49 7.3k 1.6× 2.9k 0.8× 3.6k 1.0× 3.5k 4.5× 658 0.9× 251 11.7k
K. Bridget Brosnihan United States 44 3.2k 0.7× 1.2k 0.3× 546 0.1× 1.2k 1.5× 512 0.7× 89 7.4k
Carmella Evans‐Molina United States 42 2.5k 0.5× 2.6k 0.7× 3.1k 0.8× 1.6k 2.0× 495 0.7× 170 6.7k
Janet K. Snell‐Bergeon United States 46 3.3k 0.7× 1.5k 0.4× 2.0k 0.5× 959 1.2× 238 0.3× 223 7.2k

Countries citing papers authored by Mona Landin‐Olsson

Since Specialization
Citations

This map shows the geographic impact of Mona Landin‐Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Landin‐Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Landin‐Olsson more than expected).

Fields of papers citing papers by Mona Landin‐Olsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Landin‐Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Landin‐Olsson. The network helps show where Mona Landin‐Olsson may publish in the future.

Co-authorship network of co-authors of Mona Landin‐Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Landin‐Olsson. A scholar is included among the top collaborators of Mona Landin‐Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Landin‐Olsson. Mona Landin‐Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ekblad, Eva, Björn Weström, Charlotte Erlanson‐Albertsson, et al.. (2022). Structural and immunoendocrine remodeling in gut, pancreas and thymus in weaning rats fed powdered milk diets rich in Maillard reactants. Scientific Reports. 12(1). 4039–4039. 1 indexed citations
4.
Lindqvist, Pelle G., Mona Landin‐Olsson, & Håkan Olsson. (2021). Low sun exposure habits is associated with a dose-dependent increased risk of hypertension: a report from the large MISS cohort. Photochemical & Photobiological Sciences. 20(2). 285–292. 13 indexed citations
5.
Hillman, Magnus, Björn Weström, Kataneh Aalaei, et al.. (2018). Skim milk powder with high content of Maillard reaction products affect weight gain, organ development and intestinal inflammation in early life in rats. Food and Chemical Toxicology. 125. 78–84. 23 indexed citations
6.
Lindqvist, Pelle G., E. Epstein, Mona Landin‐Olsson, et al.. (2014). Avoidance of sun exposure is a risk factor for all‐cause mortality: results from the Melanoma in Southern Sweden cohort. Journal of Internal Medicine. 276(1). 77–86. 78 indexed citations
7.
Nilsson, Charlotta, et al.. (2012). Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus. Diabetic Medicine. 29(12). e436–9. 11 indexed citations
8.
Landin‐Olsson, Mona, Jan‐Olof Jeppsson, & Gunnar Nordin. (2010). TbA1c--ny standardisering införs i Sverige. Den nya enheten blir mmol/mol.. Läkartidningen. 107. 5–3282. 1 indexed citations
9.
Landin‐Olsson, Mona, Jan‐Olof Jeppsson, & Gunnar Nordin. (2010). [HbA1c--new standardization introduced in Sweden. The new unit is mmol/mol].. PubMed. 107(51-52). 3282–5. 7 indexed citations
10.
Cugnet‐Anceau, Christine, Julie‐Anne Nazare, Maria Biörklund, et al.. (2009). A controlled study of consumption of β-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. British Journal Of Nutrition. 103(3). 422–428. 59 indexed citations
11.
Oak, Shilpa, Jared Radtke, Mona Landin‐Olsson, et al.. (2009). Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies. Journal of Immunological Methods. 351(1-2). 55–61. 5 indexed citations
12.
Oak, Shilpa, Lisa K. Gilliam, Mona Landin‐Olsson, et al.. (2008). The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proceedings of the National Academy of Sciences. 105(14). 5471–5476. 58 indexed citations
13.
Thunander, Maria, et al.. (2008). Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Research and Clinical Practice. 82(2). 247–255. 152 indexed citations
14.
Marcovina, S, et al.. (2000). Evaluation of a novel radioimmunoassay using125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. International Journal of Clinical & Laboratory Research. 30(1). 21–26. 9 indexed citations
15.
Husebye, Eystein S., Gennet Gebre‐Medhin, Jaakko Perheentupa, et al.. (1997). Autoantibodies against Aromaticl-Amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I1. The Journal of Clinical Endocrinology & Metabolism. 82(1). 147–150. 93 indexed citations
16.
Grubin, C. E., T. Daniels, Bert Toivola, et al.. (1994). A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37(4). 344–350. 351 indexed citations
17.
Hagopian, William, Allan E. Karlsen, Anders Gottsäter, et al.. (1993). Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.. Journal of Clinical Investigation. 91(1). 368–374. 160 indexed citations
18.
Gottsäter, Anders, Mona Landin‐Olsson, Per Fernlund, Åke Lernmark, & G. Sundkvist. (1993). β-Cell Function in Relation to Islet Cell Antibodies During the First 3 Yr After Clinical Diagnosis of Diabetes in Type II Diabetic Patients. Diabetes Care. 16(6). 902–910. 88 indexed citations
19.
Landin‐Olsson, Mona, K. O. NILSSON, Åke Lernmark, & G. Sundkvist. (1990). Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia. 33(9). 561–568. 91 indexed citations
20.
Landin‐Olsson, Mona, Anders Karlsson, Gisela Dahlquist, et al.. (1989). Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia. 32(6). 387–395. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin Gale Breakdown of academic impact, for papers by Peter G. Colman Breakdown of academic impact, for papers by Ruth Frikke‐Schmidt Breakdown of academic impact, for papers by Christophe De Block Breakdown of academic impact, for papers by Yasuhiko Iwamoto Breakdown of academic impact, for papers by Ian F. Godsland Breakdown of academic impact, for papers by Stephen C. Bain Breakdown of academic impact, for papers by K. Bridget Brosnihan Breakdown of academic impact, for papers by Carmella Evans‐Molina Breakdown of academic impact, for papers by Janet K. Snell‐Bergeon
Rankless by CCL
2026